We can therefore hypothesise, first, that poor prognosis in N+ breast cancer is related in a large part to a high activity of the UPS, itself related to tumour high proliferative metabolism, and second, that UBE2C might be considered as a marker of proteasome activity. The gene discussed is UBE2C; the disease is neoplasm.